graphic
News > Companies
Schering to meet targets
July 12, 2000: 11:56 a.m. ET

Drug maker tells analysts it will meet 2Q, full-year earnings estimates
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Executives with drug maker Schering-Plough Corp. told analysts Wednesday the company will meet earnings estimates in the second quarter and would be in line with forecasts for the full year.

The company did not release a full earnings report, but Richard Jay Kogan, chairman and chief executive of the company, told analysts the earnings would come in at 43 cents a share when it releases results July 25. That is the same as the estimates of analysts surveyed by earnings tracker First Call.

Kogan also said the full-year result would be in line with current forecasts of $1.64 a share.

Worldwide pharmaceuticals, which make up 84 percent of the company's total sales, continue to drive Schering-Plough's growth, he said.

Shares of Schering-Plough (SGP: Research, Estimates) fell 5/8 to 50-5/16 in trading Wednesday. Back to top

  RELATED STORIES

Merck, Schering-Plough in drug pact - May 23, 2000

Schering profit rises 22% in 1Q - May 2, 2000

  RELATED SITES

Schering Plough


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic


© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.